| Term 
 
        | what are the 4 epilepsy drugs that work by decreasing Na influx |  | Definition 
 
        | oxycarbasepine carbamazepine
 lamotrigene
 phenytoin
 |  | 
        |  | 
        
        | Term 
 
        | what are the 5 epilepsy drugs that are mixed MOA |  | Definition 
 
        | valproic acid zonlsamide
 topiramate
 Gabapentin
 pragabalin
 |  | 
        |  | 
        
        | Term 
 
        | what are the 7 epilepsy drugs that interact with GABA |  | Definition 
 
        | clonazepam lorazepam
 diazepam
 primidone
 tigabine
 vigabatrin
 phenobarbital
 |  | 
        |  | 
        
        | Term 
 
        | what are the 5 epilepsy drugs that i categorized as other |  | Definition 
 
        | gabapentin lavetfracetam
 pregabalin
 acetazolamide
 ethosuxamide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops spread from focus no effect on seizure threshold
 increases inactive state of voltage sensitive Na channels
 
 acts using monohydroxy metabolite
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops spread from focus no effect on seizure threshold
 decrease Na influx by prolonging inactive state
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increases inactivated Na channels inhibits release of glutamate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreases Na influx into neurons by prolonging active state stabilizes neuronal membranes
 reduces spread from focus
 no effect on seizure threshold
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase inactivation of Na channels (at different site than phenytoin and carbamazepine) 
 reduces threshold Ca currents in thalamic neurons (weaker than ethosuxamide)
 
 increases GABA inactivating GABA T-transaminase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increases inactive state of Na channels inhibits T type Ca channels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relative to fructose blocks Na channels
 increases GABA actvity
 blocks glutamate receptors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | long acting BDZ GABA CL ionophore complex
 CIV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | long acting BDZ GABA CL ionophore complex
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | long acting BDZ GABA CL ionophore complex
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relative to phenobarbital same MOA but effective metabolites do work (phenobarbital, phenylethlmalonamide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks GABA uptake into presynaptic terminals |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | irreversibly inhibit GABA transaminase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | enhance GABA inhibition increase threashold for neuronal firing
 inhibit spread of seizure activity from discrete focus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GABA analong increases synthesis and release decreases glutamate and aspartate release
 binds A2 subunit of voltage dependent Ca channels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | steroselective binding site in synaptic plasma membrane in CNS 
 inhibit firing without affecting mornal excitability prevents hypersynchronization of epileptiform burse firing and propogration of seizure activity
 
 binds to specific synaptic protein SV2A that effects excitability
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | analong of GABA increases GABA synthesis and release (more potent than gabaentin) 
 decreases glutamate and aspratate release
 
 blocks Na channels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | carbonic anhydrase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | reduce low threshold T Ca currents in thalamic neurons |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs have a MOA that decreases Na influx (8) |  | Definition 
 
        | oxycarbazepine carbamazepine
 lemtrigene
 phenytoin
 valproic acid
 zonidamide
 topiramate
 pregabalin
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs have a MOA that acts through a metabolite or is a prodrug (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs stop spread from a focus (3) |  | Definition 
 
        | oxycarbamepine carbamepine
 phenytoin
 phenobarbital
 levetfracetam
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs inhibit release of glutamate (4) |  | Definition 
 
        | lamotrigene topiramate
 gabapentin
 pregabalin
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs stabilize neuron membranes (3) |  | Definition 
 
        | phenytoin phenobarbitol - increase threshold
 levetfracetam - inhibit firing wo affecting normal excitability, prevents hypersynchronization and propogation of seizure
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs reduce threshold of Ca currents (4), which type of channel |  | Definition 
 
        | vaproic acid - at T channels in thalamic neurons zonlsamide - at T channels in thalamic neurons
 gabapentin - A2 subunit of voltage dependent Ca channels
 ethosuxamide - at T channels in thalamic neurons
 |  | 
        |  | 
        
        | Term 
 
        | which epilepy drugs interact with GABA (11), how |  | Definition 
 
        | valproic acid - inactivate GABA T-transaminase topiramate - increase GABA activity
 clonazepam - GABA Cl ionophore complex
 lorazepam - GABA Cl ionophore complex
 diazepam - GABA Cl ionophore complex
 primidone - enhance GABA inhibition
 tigabine - block reuptake
 vigabatrin - irreversibly inhibit GABA transaminase
 phenobarbital - enhance inhibition
 gabapentin - increase synthesis and release
 pregabalin - increase synthesis and release
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drug blocks carbonhc anhydrase inhibition |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | dizzy, somomn, fatigue, coodrination difficulty 
 hyponatremia
 
 30% cross hypersensitivty to carbamazepine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stupor, coma, resp depression, drowsiness, vertigo, ataxia, blurred vision 
 nausea, vomiting, hyponatremia, rash
 
 aplastic anemia, agranulocytosis, thrombocytopenia
 
 can induce serious liver disease (get function testing!)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | benign rash serious rash (esp in kids): SJS, toxic epidermal necrosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS depression: ataxia, behavior change, confusion, hallucinations, drowsiness 
 gingival hyperplasia
 
 corse facial features in kids
 
 histurism, GI upset, rash, lymphadenopathy, purple glove
 
 anti-arrhythmic (dont stop abruptly)
 
 interferes with B12 metabolism causing megaloblastic anemia
 
 fetal hydnation syndrome (worse in 1st trimester) cleft lip/palate, congenital heart disease, slow growth, MR
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | liver failure, pancreatitis, weight gain, insulin resistance 
 hyperammonemia encephalopathy (VHE)
 
 hepatotoxic at theraputic doses by elevating enzymes esp in kids <2yo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dizzy, solumn, fatigue, coordination difficulty, psychosis 
 renal stones, weight loss, sweating,
 
 teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | porconvulsive effect can cause status epilepticus |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | good threshold between effective dose and CNS depression 
 kids: depresses cognative performance
 
 sedation, ataxia, vertigo, morbiliform rash, CT disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dizzy, solumn, fatigue, coordination difficulty caution with impaired renal flow/dialysis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | less fatigue that gabapentin CV drug: some people feel high and report withdrawl symptoms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | drowsiness, nausea, vomiting, 10% eosinophilia, blood dysracias |  | 
        |  | 
        
        | Term 
 
        | interactions with carbamazepine 6 |  | Definition 
 
        | metabolism initiation: cemetidine, diltiazem, erythromycin, isonizad, propoxyphene 
 never use in primary generalized seizure Na inhibition makes seizure worse
 |  | 
        |  | 
        
        | Term 
 
        | interactions with phenytoin 10 |  | Definition 
 
        | inhibit phenytoin metabolism: dicumarol, cimetidine, sulfonamides, isoniazid 
 phenotyin increases P450: anti-epileptics, anti-coagulants, contraception, doxycycline, methodone, levodopa
 
 stimulates phenytoin metabolism: carbamasepine
 
 never use in primary generalized Na inhibition makes seizure worse
 |  | 
        |  | 
        
        | Term 
 
        | interactions with zonisamide |  | Definition 
 
        | decreases OC effectiveness |  | 
        |  | 
        
        | Term 
 
        | interactoins with phenobarbital |  | Definition 
 
        | drugs with hepatic metabolism, induces P450 enzymes |  | 
        |  | 
        
        | Term 
 
        | interactions with gabapentin |  | Definition 
 
        | none, able to use other AED |  | 
        |  | 
        
        | Term 
 
        | phenytoin administaration, why |  | Definition 
 
        | oral or IV IM percipitates at site of injection
 oral absorption is slow but complete in duodenum
 |  | 
        |  | 
        
        | Term 
 
        | zonisamide metabolism and elimination |  | Definition 
 
        | metabolized in liver eliminated in kidney
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV for status epilepticus |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 90% metabolized by hepatic hydroxylation |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs can you use in pregnancy |  | Definition 
 
        | phenytoin - supplement folate |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs can be used for partial seizure 7 |  | Definition 
 
        | oxycarbazepine lamotrigene
 topiramate
 vigabatrin
 gabapentin
 levetfracetam
 pregabalin
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs can be used for neuralgia (3), which type |  | Definition 
 
        | carbamasepine - trigeminal gabapentin - neuropathic pain
 pregabalin - peripherial
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs tx status epilepticus 4, which are DOC 2 |  | Definition 
 
        | phenytoin lorazepam DOC
 diazepam DOC
 phenobarbital
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs tx absence seizure 3, which are DOC |  | Definition 
 
        | valproic acid acetazolamide - alt
 ethozuximide - DOC
 |  | 
        |  | 
        
        | Term 
 
        | which epilepsy drugs tx tonic / clonic seizure |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | which epilepsy drug tx febrile seizure |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | firing of areas of neurons in brain (primary focus) which is anatomically normal 
 possibly inbalance of GABA: GABA transaminase elimase halts GABA to ensure balance in communication, if GABA is lacking it causes seizure
 |  | 
        |  | 
        
        | Term 
 
        | what percipitates a seizure 5 |  | Definition 
 
        | change in blood gas, pH, electrolytes, glucose increase in glutamate activity
 |  | 
        |  | 
        
        | Term 
 
        | explain dual order kinetics |  | Definition 
 
        | low blood levels: rate of metabolism proportional to blood level (1st order) 
 high blood levels: disporportional increase in concentration, steady state may not be reached before toxicity occurs (zero order kinetics) hepatic hydroxylation is filled up. makes t1/2 of drug meaningless
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug derived from opium (semisynthetic congers) opium like
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | all agonist and antagonists natural and synthetic morphine like
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | strone opiate analgesic often abused
 not a pharmacological word
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the ascending pain pathway |  | Definition 
 
        | noxious stimuli > nociceptor > primary afferent neuron > dorsal horn > secondary neuron (spinothalamic) > supraspinal nuclei in thalamus > limbic system and primary somatosensory cortex |  | 
        |  | 
        
        | Term 
 
        | what are the two types of primary afferent neurons / nocioceptors |  | Definition 
 
        | somatic pain A delta (Ad) fibers visceral pain C fibers
 |  | 
        |  | 
        
        | Term 
 
        | somatic pain A delta (Ad) fibers: size, composition, speed, location |  | Definition 
 
        | small unmyelinated
 fast, high threshold
 terminate in laminae I
 |  | 
        |  | 
        
        | Term 
 
        | somatic pain A delta (Ad) fibers: what do they sense, what do they cause |  | Definition 
 
        | sense mechanical and thermal cause sharp localized pain
 |  | 
        |  | 
        
        | Term 
 
        | visceral pain C fibers: size, composition, speed, location |  | Definition 
 
        | large unmyelinated
 slow
 terminate in laminae II (substantia gelatinosa)
 |  | 
        |  | 
        
        | Term 
 
        | visceral pain C fibers: what do they sense, what do they cause |  | Definition 
 
        | sense: mechanical, thermal, chemical cause: dull, diffuse, achine, burning pain
 |  | 
        |  | 
        
        | Term 
 
        | how do affernt neurons work |  | Definition 
 
        | release excitatory AA into dorsal horn (C fibers also release neuropeptides) |  | 
        |  | 
        
        | Term 
 
        | describe the decending pain pathway |  | Definition 
 
        | periaqueductal gray in midbrain and nuclei of rostroventral medulla > dorsal horn > NE/SE release > inhibit ascending pathway... 
 directly: direct synaptic inhibition
 indirectly: activate inhibitory interneurons
 |  | 
        |  | 
        
        | Term 
 
        | what are the three endogenous opioid peptides |  | Definition 
 
        | enkephalins endorphins
 dynorphin
 |  | 
        |  | 
        
        | Term 
 
        | general locations of enkephalins |  | Definition 
 
        | in interneurons 
 pain areas, emotion areas, motor areas, antonomic reflex areas, inhibitory areas
 |  | 
        |  | 
        
        | Term 
 
        | pain areas of enkephalins |  | Definition 
 
        | laminae I and II, spinal trigeminal nuclei, PAG midbrain |  | 
        |  | 
        
        | Term 
 
        | emotion areas of enkephalins |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | motor sreas of enkephalins |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | autonomic reflex areas of enkephalins |  | Definition 
 
        | nucleus tractus solitaries |  | 
        |  | 
        
        | Term 
 
        | inhibitory areas of enkephalins |  | Definition 
 
        | dorsal horn causing inhibition of secondary ascending pain neurons |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hypothalamus, nucleus tractus solitaris anterior pituitary: Co-release with ACTH in response to stress
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mangocellylar cells of hypothalamus posterior pituitary: role in fluid homeostasis
 CNS: all over, esp laminae I and II
 |  | 
        |  | 
        
        | Term 
 
        | explain how opioid receptors work |  | Definition 
 
        | Gi protein coupled receptor > adenylate cyclase > cAMP > increases K and decreases Ca conductance > inhibits neuron activity |  | 
        |  | 
        
        | Term 
 
        | what do opioids cause clinically to help pain |  | Definition 
 
        | effect transmission of pain and pain perception (I feel it but I don't care) |  | 
        |  | 
        
        | Term 
 
        | what are the classes of opioid receptors |  | Definition 
 
        | Mu (m) Kappa (k)
 Delta (d)
 65% homologous
 |  | 
        |  | 
        
        | Term 
 
        | how do opioid analgesics work (the morphine model) |  | Definition 
 
        | full agonist of Mu receptors high doses interact with other opioid receptors
 |  | 
        |  | 
        
        | Term 
 
        | 12 CNS side effects of morphine |  | Definition 
 
        | analgesia euphoria
 mood alteration
 dec cough reflex in medulla
 nausea/emetic: stimulation of chemoreceptor in postrema of medulla
 sleep
 increased ICP (NO use in trauma!!)
 hypothalamus: alters temp equlibrium
 neuroendocrine: dec testosteone and cortisol
 miosis
 convulsions at high dose (esp kids)
 |  | 
        |  | 
        
        | Term 
 
        | explain how opioids effect the hypothalamus |  | Definition 
 
        | alters temp equlibrium acute: lowers
 chronic: increases
 |  | 
        |  | 
        
        | Term 
 
        | explain how opioids cause miosis |  | Definition 
 
        | Mu and K agonists constrict pupil via parasympathetic |  | 
        |  | 
        
        | Term 
 
        | what do opioids do to respiration (2) |  | Definition 
 
        | decrease response to CO2 in brainstem decreasing respiration CAUSES DEATH IN MORPHINE POISONING
 max effect 5-10 min after IV administration
 
 cough: decreases cough reflex in medulla
 |  | 
        |  | 
        
        | Term 
 
        | what do opioids to do GI (8) |  | Definition 
 
        | nausea/emetic: stimulation of chemoreceptor in postrema of medulla 
 stomach: Mu agonist dec HCl
 
 Si: dec secretions, delay pooing, increase water absorption
 
 LI: propulsive peristalsis stopped causing constipation
 
 billiary: sphincter of oddi constricts and increases pressure and spasm in common bile duct
 
 bladder: stops voiding reflex
 |  | 
        |  | 
        
        | Term 
 
        | CV effects of opioids (2) |  | Definition 
 
        | when standing causes histamine release leading to peripherial vasodilation and orthostatic hypotension |  | 
        |  | 
        
        | Term 
 
        | effects of opioids in uterus (2) |  | Definition 
 
        | prolong labor respiratory depression in neonate
 |  | 
        |  | 
        
        | Term 
 
        | effects of opioids in skin (1) |  | Definition 
 
        | dilation of cutaneous vessels in flushing |  | 
        |  | 
        
        | Term 
 
        | all opioids have tolerance, cross tolerance, and physical dependence. define each |  | Definition 
 
        | tolerance: higher doses are needed to produce same response 
 cross tolerance: across all opioids
 
 physical dependence: body adapts to presence of drug and requires it to function. termination causes withdrawl
 |  | 
        |  | 
        
        | Term 
 
        | signs of withdrawl from opioids |  | Definition 
 
        | pupil dilation hyperventilation
 diarrhea
 dysphoria
 |  | 
        |  | 
        
        | Term 
 
        | interactions with opioids (3) |  | Definition 
 
        | MAOI: hyperpyrexic coma 
 sedative/hypnotics: increased CNS depression, respiratory depression
 
 TCA/anti-psych: increased sedation, increased respiratory depression
 |  | 
        |  | 
        
        | Term 
 
        | in order from least to most effective list the 9 pain killers less effective than morphine |  | Definition 
 
        | diphenyloxylate D dextropropoxyphene 1/20
 pentazocine 1/15
 codine 1/12
 tramadolol 1/12
 mepheridine 1/10
 hydrocodone 1/13
 oxycothinin 2/3
 oxycodone 2/3
 |  | 
        |  | 
        
        | Term 
 
        | what are the two drugs that have the same effectiveness as morphine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 6 drugs more effective than morphine from least to most potent |  | Definition 
 
        | diacetylmorphine 3-5x butorphanol 5x
 hydromorphone 7x
 buprenophine 20-50x
 fentynil 80x
 sufentanil 800x
 |  | 
        |  | 
        
        | Term 
 
        | what are the two "other" pain killers from least to most potent |  | Definition 
 
        | diphenyloxylate tramadolol
 |  | 
        |  | 
        
        | Term 
 
        | what are the 5 codine/codine derivative pain killers from least to most potent |  | Definition 
 
        | dextropropoxyphene codine
 hydrocodone
 oxycotinin
 oxycodon
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 mixed pain killers from least to most potent |  | Definition 
 
        | pentazocine nalbuphine
 butorphanol
 buprenophine
 |  | 
        |  | 
        
        | Term 
 
        | what are the 7 opioid pain killers from least to most potent |  | Definition 
 
        | mepheridine methadone
 morphine
 diacetylmorphine
 hydromorphone
 fentynil
 sufentanil
 |  | 
        |  | 
        
        | Term 
 
        | which pain killers cannot be taken oral (7) |  | Definition 
 
        | morphine* can but it sucks nalbuphine
 diacetylmorphine
 butorphanol
 buprenophine
 fentynil
 sufentanil
 |  | 
        |  | 
        
        | Term 
 
        | what painkillers stronger than morphine or equal to can be taken oral (2) |  | Definition 
 
        | morphine* but it sucks hydromorphone
 |  | 
        |  | 
        
        | Term 
 
        | what painkillers can be taken IV IM (9) |  | Definition 
 
        | mepheridine methadone
 morphine
 nalbuphine
 butorphanol
 hydromorphone
 buprenophine
 fentinyl
 sufentanil
 |  | 
        |  | 
        
        | Term 
 
        | which pain killers can be taken SC (3) |  | Definition 
 
        | morphine nalbuphine
 hydromorphone
 |  | 
        |  | 
        
        | Term 
 
        | what painkiller can be taken nasal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what painkiller can be taken rectal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what pain killer can be taken sublingual |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what pain killer can be taken transdermal/transmucosal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | which pain killers have a different metabolism, describe it (4) |  | Definition 
 
        | codine: 10% converted to morphine 
 mepheridine: metabolized via N-demythylation to normepheridine
 
 morphine: conjugated with glycorinic A to make morphine 6, excreted as morphine 3
 
 diacetylmorphine: hydrolyzed to 6-monoacetylmorphine (lipid soluble), hydrolyzed to morphine
 |  | 
        |  | 
        
        | Term 
 
        | MOA of the mixed opioids (4) |  | Definition 
 
        | pentazocine: partial Mu antagonist, K agonist 
 nalbuphine: strone K agonist, Mu antagonist
 
 butorphanol: strong K agonist, Mu antagonist
 
 buprenophinel: strong K agonist, Mu antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit NE/SE weak Mu agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | oxycodone time release in higher doses |  | 
        |  | 
        
        | Term 
 
        | which painkillers have a long duration (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what pain killer has a rapid onset and short duration |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | unique SE of dextropropxyphene |  | Definition 
 
        | not analgesic not addictive
 low toxicity
 supresses CNS
 |  | 
        |  | 
        
        | Term 
 
        | unique use of dextropropxyphene |  | Definition 
 
        | antitussive: cough supression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | high dose increases catecholamines and thus BP |  | 
        |  | 
        
        | Term 
 
        | unique use of pentazocine |  | Definition 
 
        | help with withdrawl, releave some pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | often combined with ASA/APAP, NSAID antitussive
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | analgesia not completely reversed by antagonist seizure - never in epileptic!!
 little respiratory depression
 interacts with SSRI!!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | no CV/pupil effects when oral metabolite cause tremor, twitch, convulsions
 EVEN THOUGH ALL SHOULDNT GO WITH MAOI, THIS ONE REALLY SHOULDENT
 |  | 
        |  | 
        
        | Term 
 
        | unique use of mepheridine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | unique use of hydrocodone |  | Definition 
 
        | often combined with ASA/APAP, ibprofen |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | often combined with ASA/APAP |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | help with withdrawl (because it has a more mild one) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | low abuse depresses respiration
 |  | 
        |  | 
        
        | Term 
 
        | unique SE diacetylmorphine |  | Definition 
 
        | fast euphoria due to lipid solubility |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased workload on heart |  | 
        |  | 
        
        | Term 
 
        | unique use of butorphanol |  | Definition 
 
        | not good for chronic pain, acute only |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | less respiratory depression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | added to naltrexone to make auboxone to maintain opioid dependent pt |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | interaction with deoperidol (neuroleptic anesthesia) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | which pain killers are used for cough supression |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what pain killers are used to help with withdrawl (3) |  | Definition 
 
        | pentazocine methadone
 buprenophine
 |  | 
        |  | 
        
        | Term 
 
        | what pain killers are often combined with ASA/APAP, of other mild pain killer |  | Definition 
 
        | codine hydrocodone
 oxycotinin
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 opioid antagonists |  | Definition 
 
        | naloxone naltrexone
 nalmefene
 methylabaktrexibe
 |  | 
        |  | 
        
        | Term 
 
        | naloxone: administration, duration, distribution |  | Definition 
 
        | IV, IM, SC duration 1-4h
 completely metabolized 1st pass
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | tx opioid dependency and toxicity |  | 
        |  | 
        
        | Term 
 
        | naltrexone: administration, duration |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid toxicity and dependence alcoholism
 |  | 
        |  | 
        
        | Term 
 
        | nalmefene: administration, use |  | Definition 
 
        | IV pure opioid antagonist (best) for tx opioid dependency and toxicity
 |  | 
        |  | 
        
        | Term 
 
        | methylabaktrexible: administration, distribution and SE |  | Definition 
 
        | SC unable to cross BBB so no pain killing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent morphine constipation |  | 
        |  | 
        
        | Term 
 
        | what is the restriction of all opioid antagonists |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the story used for pain killers less than morphine |  | Definition 
 
        | i died from phenyl dex tried to operate
 he penetrated
 the code in my
 tramp stamp
 me phrend the dean
 stole my hydrocodone
 oxycotinin
 and oxycodone
 |  | 
        |  | 
        
        | Term 
 
        | what is the story used for paiin killers same sa morphine |  | Definition 
 
        | meth done morphed into a
 nail biting pheind
 |  | 
        |  | 
        
        | Term 
 
        | what is the story used for pain killers more than morphine |  | Definition 
 
        | heroine butt and or oral
 hydrates me
 but phrends no me
 fender
 suffers
 |  | 
        |  | 
        
        | Term 
 
        | how is serotonin made and broken down |  | Definition 
 
        | L tryptophan ingested > facillitated transport into brain (concentration in blood relation to other AA)>
 RATE LIMITING: tryptophan hydroxylase + O2 + pteridine >
 serotonin >
 MAO >
 5-hydroxyindole acetic acid >
 transport out of brain (inhibited by probenecid) >
 small amt in urine (unless malignant carcinoid)
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 serotonin receptors how do they work, where are they located |  | Definition 
 
        | all 16 in brain, not all in body 
 1: Gi: inc K, hyperpolarize, inhibit
 2: Gq: dec K, depolarize, excite
 3: ion: dec K, inc Na, depolarize (fast)
 4: dec K, hyperpolarize, excite
 |  | 
        |  | 
        
        | Term 
 
        | functions of serotnin in blood and vessels 2 |  | Definition 
 
        | platelets contact endothelium which releases 5HT which goes to 5HT2 on platelets causing aggregation and vasoconstriction 
 vasoconstriction in eplanchnic, renal, pulmonary, cerebral)
 |  | 
        |  | 
        
        | Term 
 
        | functions of serotonin in lungs 2 |  | Definition 
 
        | pulmonary vessel constriction 
 constriction of bronchioles
 |  | 
        |  | 
        
        | Term 
 
        | functions of serotonin in GI |  | Definition 
 
        | enterochromaffin cells make it, store it, and use it. released bia vagal stimulation to cause emesis
 |  | 
        |  | 
        
        | Term 
 
        | functions of serotonin in CNS 9 |  | Definition 
 
        | sleep, cognotion, sensory, motor, temp, pain, appetite, sex, hormone secetion |  | 
        |  | 
        
        | Term 
 
        | is serotonin hydrophillic or phobic what does this mean about its distribution and function |  | Definition 
 
        | phillic cannot cross BBB, must be made in brain
 
 not all cells that use it make it so they need transporter
 |  | 
        |  | 
        
        | Term 
 
        | why can serotonin be hallucinogenic |  | Definition 
 
        | N and O methylated properities |  | 
        |  | 
        
        | Term 
 
        | what is the chemical class of serotonin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what compound is relative to serotonin, how is it foemed |  | Definition 
 
        | melatonin N acetylation
 O methylation
 in pineal gland controlled by light
 |  | 
        |  | 
        
        | Term 
 
        | ergot: where does it come from, what does it to (biochem and physio) |  | Definition 
 
        | fungus on rye and grain 
 interacts with 5HT, D, and a receptors different interaction in different systems
 
 vasoconstriction, cerebral constriction, supress sensory neuropeptides
 |  | 
        |  | 
        
        | Term 
 
        | complication of all ergots |  | Definition 
 
        | vasoconstriction can cause gangrene and misscarriage |  | 
        |  | 
        
        | Term 
 
        | migraine: family hx, sex, onset, location, character, duration, associated symptoms |  | Definition 
 
        | hx: yes sex: females
 onset: variable
 location: usually unilateral
 character: pulse, throb
 duration; 2-72h
 symp: aura (15%), photosensitive, sound sensitive, pale, nausea, vomiting. aggrevated by physical activity
 |  | 
        |  | 
        
        | Term 
 
        | cluster headache: family hx, sex, onset, location, character, duration, associated symptoms |  | Definition 
 
        | hx: no sex: males
 onset: in sleep
 location: behind/around eye
 character: sharp, steady
 duration: 15-90min
 symp: uni/bilateral sweating, flushing, congestion, ptosis, lacrimation, pupillary changes
 |  | 
        |  | 
        
        | Term 
 
        | tension headahce: family hx, sex, onset, location, character, duration, associated symptoms |  | Definition 
 
        | hx: yes sex: females
 onset: stress
 location: bilateral around head
 character: dull, persistant, tight
 duration: 30 mim - 7d
 symp: mild photophobia, noise phobia, anorexia
 |  | 
        |  | 
        
        | Term 
 
        | mild migraine: definition, tx |  | Definition 
 
        | occasional throbbing, no major impairment 
 mild analegesics combo analegesics, amiemetics
 |  | 
        |  | 
        
        | Term 
 
        | moderate migraine: definition, tx |  | Definition 
 
        | some impairment in function, nausea 
 combination anaglesics, ergots, sumatriptan, amiemetics
 |  | 
        |  | 
        
        | Term 
 
        | severe migraine: definition, tx |  | Definition 
 
        | >3/mo, functional impairment, nausea, vomiting 
 ergot, sumatriptan, animetics, prophylaxis
 |  | 
        |  | 
        
        | Term 
 
        | what drugs are used in migraine prophylaxis 5, what is #1 |  | Definition 
 
        | #1 B blocker Ca channel blocker
 TCA
 serotonergic agonist
 MAOI
 |  | 
        |  | 
        
        | Term 
 
        | what B blocker are used in migraine prophylaxis 5 |  | Definition 
 
        | propranolol timolol
 atenolol
 nadolol
 metoprolol
 |  | 
        |  | 
        
        | Term 
 
        | what TCA are used in migraine prophylaxis 2 |  | Definition 
 
        | amitriptyline nortryptyline
 |  | 
        |  | 
        
        | Term 
 
        | what serotonergic agonist are used in migraine prophylaxis 2 |  | Definition 
 
        | methylserglide cyproheptadine
 |  | 
        |  | 
        
        | Term 
 
        | what MAOI are used in migraine prophylaxis 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are triggers someone can avoid for migraine |  | Definition 
 
        | alcohol, foods, irregular sleep, stress, time zone shift, altitude, barometric pressure, menstural cycle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | citalopram paroxetine
 sertaline
 fluoxetine
 fluboxamine
 escitalopram
 
 depression, PMDD, OCD, anxiety, migrane prophylaxis
 |  | 
        |  | 
        
        | Term 
 
        | serotoniin agonists and their receptors (3) |  | Definition 
 
        | sumatriptan: 5HT-1D LSD: 5HT-2A, 2C
 buspirone: 5HT-1A
 |  | 
        |  | 
        
        | Term 
 
        | serotonin antagonist and their receptors: |  | Definition 
 
        | odansteron: 5HT-3 risperidone: 5HT- 2A, 2C, D
 cyproheptadine: 5HT-2A
 methysergide: 5HT-2A, 2C
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ergoloid methylate ergonovine
 ergotamine
 bromocryptine
 methysergide
 dihydroergotamine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | constrict vessels supress release of neuropeptides
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non selective ergot derivative
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K channel open, hyperpolarization, inhibitory |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit 5HT-2A on smooth muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LSD and methylergovine relative 
 inhibits vasoconstriction and vasopressin
 inhibits 5HT-2A, 2C on smooth muscle
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | psychic alterations hallucinations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | gynecomastia: D receptor inhibition allows activity of prolactin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inflammatory fibrosis (esp heart) in prolonged tx |  | 
        |  | 
        
        | Term 
 
        | administration sumatriptan 3 |  | Definition 
 
        | IV - NO causes coronary vasospasm oral - poor absorption
 SC
 nasal
 |  | 
        |  | 
        
        | Term 
 
        | administration odansteron 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | administration methysergide |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | nausea and vomiting (esp from chemo due to enterochromaffin release of 5HT in SI stimulation emesis 
 vagal afferents through 5HT-3 receptors initiate vomiting, this is stopped
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | migraine prophylaxis counteract sex SE of SSRI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | migraine prophylaxis vascular headache prophylaxis
 depression
 schizophrenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | migraine depression
 schizophrenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase brain metabolism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase strength, duration, and frequency of uterine contraction to decrease uterine bleeding |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | post partum hemorrhage abortion bleeding control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | caffiene + belladonna + phenobarbitol |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | ergot derivative inhibit vasoconstriction and vasopressin
 inhibit 5HT action on smooth muscle
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | caffiene + belladonna + phenobarbitol |  | 
        |  | 
        
        | Term 
 
        | administration ergotamine |  | Definition 
 
        | PO, SL, retro rocks 
 should not exceede 6mg/d or 10mg/wk
 take 1-2mh/0,5h until relief
 |  | 
        |  | 
        
        | Term 
 
        | administration of dihydroergotamine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | CP, coronary vasoconstriction, tachy, brady 
 numbness, tingling of fingers and toes
 
 nausea, vomiting
 |  | 
        |  | 
        
        | Term 
 
        | contraindications of ergotamine 4 |  | Definition 
 
        | pregnancy, peripherial vascular disease, hepatic/renal impairment |  | 
        |  | 
        
        | Term 
 
        | contraindications of dihydroergotamine 4 |  | Definition 
 
        | pregnancy, peripherial vascular disease, hepatic/renal impairment |  | 
        |  | 
        
        | Term 
 
        | interactions of ergotamine 4 |  | Definition 
 
        | azithro, dirithro, clathro, erythromycin causes ergotism (HTN, ischemia) |  | 
        |  | 
        
        | Term 
 
        | interactions of dihydroergotamine 4 |  | Definition 
 
        | azithro, dirithro, clathro, erythromycin causes ergotism (HTN, ischemia) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acute migraine or cluser headache |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | migraine or cluster headache |  | 
        |  | 
        
        | Term 
 
        | what is the most common supraventricular arrhythmia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | describe EKG in premature atrial contraction, cause |  | Definition 
 
        | until early P wave/ORS (hides normal P in it) followed by pick back up of sinus SA node is resetting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | asymptomatic- none BB, type Ic
 |  | 
        |  | 
        
        | Term 
 
        | describe EKG in premature junctional complex, cause |  | Definition 
 
        | sinus rhythm followed by premature abnormal P wave (upside down or hidden) and QRS with wide S 
 complex originates from AV node/His
 |  | 
        |  | 
        
        | Term 
 
        | Tx premature junctional complex 2 |  | Definition 
 
        | BB type IC anti arrhythmics
 |  | 
        |  | 
        
        | Term 
 
        | cause of physiological sinus tachycardia 5 |  | Definition 
 
        | pain, exercise, fever, anxiety, hypotension, anemia |  | 
        |  | 
        
        | Term 
 
        | cause of inappropirate sinus tachycardia |  | Definition 
 
        | increase HR with normal activity due to SNS increase, PNS decrease, viral illness causing autonomic dysutonomia |  | 
        |  | 
        
        | Term 
 
        | signs of inappropirate sinus tachycardia |  | Definition 
 
        | palpitations, CP, GI upset, syncope |  | 
        |  | 
        
        | Term 
 
        | TX inappropirate sinus tachycardia 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | describe the EKG for AFib |  | Definition 
 
        | irregular irregular rapid ventricles 120-160, atria 500
 fine fibrillations of P waves with irregular random QRS
 |  | 
        |  | 
        
        | Term 
 
        | physiology of AFib, complications |  | Definition 
 
        | atria automaticity and reentry mostly at atria and pulmonary veins 
 blood pools and clots in atria apendages and causes thrombus and stroke
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acute hyperthyroid acute alcohol/drugs
 post-op
 coronary disease
 SVA - AV reentry
 increases with age 5%>75yo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | asymptomatic fatigue
 SOB
 syncope
 exercise intolerance
 palpitations/angina
 |  | 
        |  | 
        
        | Term 
 
        | risk factors for stroke 8 |  | Definition 
 
        | valve disease mechanical valve
 previous thromboembolism
 heart failure
 systole dysfunction
 HTN
 DM
 age
 |  | 
        |  | 
        
        | Term 
 
        | explain the CHAD2 score scoring and what treatment it correlates with |  | Definition 
 
        | CHF, HTN, DM, >75yo = 1 previous stroke/TIA = 2
 
 0= no therapy / aspirin
 1= aspirin / warfarin
 2 = warfarin / thrombin inhibitor
 |  | 
        |  | 
        
        | Term 
 
        | what drug is a trombin inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how is asymptomatic AFib treated |  | Definition 
 
        | if <100BPM then give anticoag according to CHAD2 
 if >100bph then try BB, CCB, digoxin. if this dosent work try antiarrhythmic...
 A: if has CAD then amioderone, soditol, dofetilide
 B: if has LV dysfunction, tachy, cardomyopathy then use limited soditol
 C: if has LVH/HTN then use fleconide or class 1C
 
 if this dosent work ablate
 |  | 
        |  | 
        
        | Term 
 
        | how is symptomatic stable AFib treated |  | Definition 
 
        | IV heparin + amiodorine, drocamamide, or dofetilide ibuilid
 
 maintain with direct thrombin inhibitor 1 mo
 CCB, BB, or digoxin to control ventricle rate
 quinidine or disopyramide
 
 if this dosent work ablate
 |  | 
        |  | 
        
        | Term 
 
        | how is symptomatic unstable AFib treated |  | Definition 
 
        | IV heparin TEE if >24h
 synch cardiovert biphasic 200J
 
 maintain with direct thrombin inhibitor 1 mo
 CCB, BB, or digoxin to control ventricle rate
 quinidine or disopyramide
 
 if dosent work ablate
 |  | 
        |  | 
        
        | Term 
 
        | when do you ablate, 3 types |  | Definition 
 
        | when all TX dosent work when LV problems occur
 
 focus: ablate near pulmonary veins
 
 AV: eliminate and put in pace maker
 
 coxmaze: ablate all reentry spots
 |  | 
        |  | 
        
        | Term 
 
        | describe an EKG in AFlutter / microreentrant atrial tachycardia |  | Definition 
 
        | regular irregular atria 200-300
 ventricles 130-150
 less tolerated than AFib
 
 spiked P waves with regular ventricle contraction between many
 |  | 
        |  | 
        
        | Term 
 
        | descirbe a multifocal atrial tachycardia EKG |  | Definition 
 
        | P waves with at least 3 different morphlogies |  | 
        |  | 
        
        | Term 
 
        | cause of multifocal atrial tachycardia 2 |  | Definition 
 
        | pulmonary or septic infection |  | 
        |  | 
        
        | Term 
 
        | TX multifocal atrial tachycardia 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what do you never use in multifocal atrial tachycardia 4 |  | Definition 
 
        | BB amioderone
 flecinide
 propefanone
 |  | 
        |  | 
        
        | Term 
 
        | what does a AV reentry tachycardia / proxysmal supraventricular tachycardia look like, cause |  | Definition 
 
        | rate 150-250 atria and vantricles both contract
 retrograde P waves
 
 AV node has two pathways: 1 slow, 1 fast. current goes doen slow and up fast
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | teens - 30s alcohol, drugs, excitement
 no underlying heart disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | avoid trigger ablation
 B/Ca blocker
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. vasovagal 2. IV adensine or IV class IV
 3. maintience: CCB, BB, digoxin
 |  | 
        |  | 
        
        | Term 
 
        | what does an accelerated junctional rhythm EKG look like, cause |  | Definition 
 
        | 50-99 depolarization near the AV node or on it
 abnormal P waves or none
 |  | 
        |  | 
        
        | Term 
 
        | cause accelerated junctional rhythm 2 |  | Definition 
 
        | digitoxin toxicity ablation of SA
 |  | 
        |  | 
        
        | Term 
 
        | TX accelerated junctional rhythm 3 |  | Definition 
 
        | correct toicity class 1A or 1C
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypoxia- copd Ischemia + irritability
 Sympathetic
 Drugs- BB, digoxin, cocaine
 Electrolyte- dec K, inc Ca
 Brady/tachy
 Stretch- LVH/HTN
 |  | 
        |  | 
        
        | Term 
 
        | explain the ion movements in the 4 phases of cardiac muscle contraction |  | Definition 
 
        | 4. K leaks out 0: Na rush in
 1: Na slows, K rush out
 2: K rush out, Ca rush in
 3: K rush out
 4: K leaks slowly
 |  | 
        |  | 
        
        | Term 
 
        | explain the state of the Na gates in cardiac muscle contraction |  | Definition 
 
        | 4: resting - resting 0: M gates open - open
 1: H gates close  - absolute/effective refractory, inactive
 2: absolute/effective refractry
 3: switches mid phase to relative refractory
 4: resting
 |  | 
        |  | 
        
        | Term 
 
        | explain the ion movements in the phases of SA/AV contraction |  | Definition 
 
        | 4: Na leaks slowly in 0: Ca rushes in
 3: K rushes out
 4: Na leaks in
 |  | 
        |  | 
        
        | Term 
 
        | explain how to read the boxes on EKG |  | Definition 
 
        | 1 little = 0.04s 1 big = 0.2 sec, 0.5mV
 
 2 big = 1mV
 5 big = 1 sec
 
 30 big = 6 sec
 # peaks x 10 = rate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops for >1 beat (3 sec is ok in athlete) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | channel blocking dosent work well in resting (4) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ca overload SNS
 digitoxin
 MI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dec HR de K
 prolonged 3
 prolonged QT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the three conditions needed for reentry |  | Definition 
 
        | 1. obsticle 2. unidirectional block
 3. long enough to outlast refractory
 |  | 
        |  | 
        
        | Term 
 
        | why are reentrys scary for pt |  | Definition 
 
        | AFib will be accelerated if it happens and cause m ore deterioration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PR>0.12 wide QRS
 D waves in some leads
 consistantly abnormal P waves
 |  | 
        |  | 
        
        | Term 
 
        | what pathway does WPW take |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what pathway does lown ganong levine take |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what does lown ganong levine EKG look like |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how is a reentry treated 4 |  | Definition 
 
        | vasovagal IV adenosine or diltzem
 maintience: BB, CCB, digoxin, fleccanide, procamide
 |  | 
        |  | 
        
        | Term 
 
        | how is a person with reentry in AFib treated |  | Definition 
 
        | 1. cardiovert 2. procanamide, ibutalide, amioderone
 |  | 
        |  | 
        
        | Term 
 
        | what does a 1st deg AV block look like |  | Definition 
 
        | slowed conduction through node and tissue common, asymptomatic, PR>200ms
 |  | 
        |  | 
        
        | Term 
 
        | what does a mobitz type 1 (wenchebach) look like |  | Definition 
 
        | usually benign block on or by node
 progressive lengthening of PR until one is dripped
 |  | 
        |  | 
        
        | Term 
 
        | what does a mobitz type II look like |  | Definition 
 
        | block below AV node can progress to 3rd deg may need pacemaker
 consistant PR interval until one is dropped
 |  | 
        |  | 
        
        | Term 
 
        | what does a 3rd deg AV block look like |  | Definition 
 
        | AV dissociation, ventricles and atrial are independent block at AV, upper BB, lower BB
 ventricles 30-45
 atria 60-100
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | autnomic- vasovagal lyme, chagas, sphyilis
 metabolic: ince K, dec adrenal
 drugs: digoxin, CCB, adenosine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type 1: none or atropine/epi/amnioderone 
 type 2: atropine/eip/amnioderone
 
 type 3: atropine/epi/amnioderone or pacemaker
 |  | 
        |  | 
        
        | Term 
 
        | what does a EKG for premature ventricular complex look like, cause |  | Definition 
 
        | normal sinus with an out of place wide QRS, hides P wave comes from purkinje
 compensatory pause
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bigeminy: sinus/PVC/sinus/PVC/snus tigeminy: sinus/sinus/PVC/sinus/sinus/PVC
 pair/couple: sinus/PVC/PVC/sinus/PVC/PVC/sinus
 |  | 
        |  | 
        
        | Term 
 
        | what increases risk of PVC 3 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what should you NEVER take with a PVC |  | Definition 
 
        | antiarrhythmics = DEATH prolong QT |  | 
        |  | 
        
        | Term 
 
        | what is a complication of PVC |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | asymp- nothing symp- BB, K channel blocker
 |  | 
        |  | 
        
        | Term 
 
        | describe the 2 kinds of VTach EKG |  | Definition 
 
        | monomorphic: large repeating, regular QRS polymorphic: oscilating sizes of QRS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | origin below bundle of His sustained |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sustained: >30sec, >3PVC nonsustained: <30sec
 |  | 
        |  | 
        
        | Term 
 
        | what drugs should you NEVER use in VTach 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how is someone who is stable with VTach tx |  | Definition 
 
        | satolol amoderone
 phenytoin
 lidocaine - MI
 propafenene
 
 cardiovert - synch
 
 maintain: quinidine, phenytoin, mexiletine-MI, dysopramide, sotalol
 |  | 
        |  | 
        
        | Term 
 
        | how is someone who is unstable with VTach tx |  | Definition 
 
        | cardiovert 
 maintain: quinidine, phenytoin, mexiletine-MI, dysopramide, sotalol`
 |  | 
        |  | 
        
        | Term 
 
        | describe the 2 EKG types for VFib |  | Definition 
 
        | coarse: spiky fibrillations fine: small fibrillations
 |  | 
        |  | 
        
        | Term 
 
        | VFib: 2 types, tx, effect in blood |  | Definition 
 
        | no CO primary: no CHF
 secondary: with CHF
 TX: asnch cardiovert
 |  | 
        |  | 
        
        | Term 
 
        | what is the cause of long QT syndrome |  | Definition 
 
        | defect in cardiac ion channel causing repolarization and prolonged plateau |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | implant defiv ig hx arrahytmic or syncope avoid long QT drugs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | erythromycin clathromycin
 procanamide
 quinidine
 flecanide
 sotalol
 amioderone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | evaluation of tachycardia |  | Definition 
 
        | EKG 24h holder
 telemetry
 electrophysiolgy
 ECHO stress test
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | autonimic dysruption sick sinus syndrome
 hypothyroid
 hypotension
 hypothremia
 physiological - athlete
 inflammatory - pericarditis
 structural heart disease - CAD
 vasovagal
 BB
 CCB
 digoxin
 lithium
 methadone
 K channel blocker
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block Na channels in abnormal high frequency rhythms affinity for open/inactive channels
 |  | 
        |  | 
        
        | Term 
 
        | MOA of class 1 A-C, half life |  | Definition 
 
        | A: N and K block, 1-10sec. increase ERP, supress 0 
 B: Na block. decrease ERP, increase ) slope.
 
 C: Na, Ca, K blocker. depress slope 0, decrease max depolarization
 |  | 
        |  | 
        
        | Term 
 
        | explain how the class 1A-C graph looks |  | Definition 
 
        | A: lengthens 0 slope, lower plateu height, elongated 3 
 B: lengthens 0 slope less than A, shortens 3
 
 C: lengthens 0 slope most, shortens plateau height
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | quinidine procanamde
 disopyramide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lidocaine mexiletine
 phenytoin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | B adrenergic agonist lengthen (decrease) slope of 0 and 4 (shift right)
 
 decrease automaticity at SA, HR, CO
 lengthen PR
 |  | 
        |  | 
        
        | Term 
 
        | what drugs decrease mortality in arrhythmia pt |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 4 B blockers used for arrhythmia and when |  | Definition 
 
        | propanolol, atenolol, metoprolol: decrease sudden cardiac death after MI arrhythmia 
 esmolol: shor tacting, IV acute arrhythmia
 |  | 
        |  | 
        
        | Term 
 
        | why is esmolol short acting |  | Definition 
 
        | metabolized by RBC t1/2 9 min |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K channel blockers elongaed ERP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sotalol amiodarone
 dronedarone
 dofetilide
 ibutilid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ca channel blockers increase slow of 0, elongate ERP
 increase AV.SA conduction
 
 block inactive and active Ca channels mostly at SA/AV node
 increase PR due to AV delay
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | dofetilide/ibutilid: administration, use, SE |  | Definition 
 
        | IV acute NOT for long duration AFib/Flutter they dont respond
 SE torsades
 
 USE: drug cardiovert in WTD arrhythmia, AFib, AFlut
 |  | 
        |  | 
        
        | Term 
 
        | amiodarone, dronedarone MOA |  | Definition 
 
        | blocks Na, Ca, K increases QRS, PR, QT
 |  | 
        |  | 
        
        | Term 
 
        | SE amniodarone, droendarone |  | Definition 
 
        | sinus brady PULMONARY ACEOLITIS/FIBROSIS
 hepatotoxicity
 photosensitivity
 thyroiditis/blue skin- amioderone
 |  | 
        |  | 
        
        | Term 
 
        | use: amniorarone, droendarone |  | Definition 
 
        | ANY supraventricular tachycardia drug cardiovert: AFib/flut (ok with CAD), VTac, AV Block, WPW tachyarrhythmia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prolong QT ERP prolong
 B blocker dec SA automaticity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | EAD bradycardia
 dyspnea
 fatigue
 torsades
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOST MI maintance post-VTach
 drug cardiovert- VTach, LV dysfunction and CAD asymp AFib/Flut
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimalaria anti-M inc HR
 a1 blocker dec HR and cause hypotension and long PR
 widen QRS and QT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mortality in non life threat arrhythmia hypertension
 vertigo
 tinnutis
 headache diarrhea
 torsades
 AFib/flutter (due to dec K)
 hypokalemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | shorted t1/2 acetylated to NAPA which blocks K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mortality in non-life threat arrhythmia hypotension
 lupus like due to NAPA acetylation
 torsades (hypokalemia)
 |  | 
        |  | 
        
        | Term 
 
        | disopyramide: administration, MOA |  | Definition 
 
        | oral anti-M dec HR
 decrease PR interval
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mortality in non life threat arrhythmia hypotension
 glaucoma
 dry mouth
 urinary retention
 constipation
 torsades
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | local anastetic decreases automaticity in purkinje blocking NA |  | 
        |  | 
        
        | Term 
 
        | lidocaine administration and exretion |  | Definition 
 
        | IV high first pass eliminated in liver
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drowsiness slurred speech
 confusion
 convlusions
 |  | 
        |  | 
        
        | Term 
 
        | administration and MOA mexiletine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticonvulsant blocks NA and purkinke
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vertigo confusion, gingival hyperplasia P450 inducer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | effects normal heart prolongs AP in atria and ventricles
 inc PR, QRS, QT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mortality in ventricle arrhythmia blurred vision
 dizzy
 headache
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | flecanide for life threatning ventricular arrhythmias |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased mortality in non life threating arrhythmia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | accelerated junctional rhythm maintience VTach/VFib
 maintience AFib/Flut
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | accelerated junctional rhythm drug cardiovert WPW arrhythmia
 maintain WPW
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | accelerated junctional rhythm maintain AFib/Flut
 maintain VFib/Tach
 drug cardiovert WPW arrhythmia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chem cardiovert VTach/Fib MI |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maintain aftr VTach/Fib MI |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maintain aftr VTach/Fib MI chem cardiovert VTach/Fib MI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | premature atrial contraction junctional premature complex
 not responding asymptomatic AFib/Flutter with HTN/LVH
 accelerated junctional rhythm
 proprafenone: cardiovert VTach/Fib
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prematyre atrial contraction junctional premature complex
 inappropirate sinus tachycardia
 maintain AFib/Flut
 maintain PST/AV reentry
 dec symp ot PVC
 maintain WOW
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maintain AFib/Flut multifocal atrial tachycardia
 PST/AV reentry
 maintain WPW
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase aytomaticity increase refractory in opurkinjue
 decrease refractory in ventricles and atria
 parasympathetic via vagus increases PR and and dec conduction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased CA and automaticity causes DAD extra systole
 tachycardia
 PVC
 fibrillation
 visual changes (yellow)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maintain AFib/Flut maintain PST
 maintain WPW
 VTACH PROPHYLAXIS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | high dose activates Gi decreasing Ca current decreasing conduction velocity increasing ERP decreasing AV velocity t1/2 8sec must be IV bolus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | flushing, CP, hypotension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DOC IV bolus supraventricular tachycardia PST/AV reentry
 WPW
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decrease ectopic pacemakers esp from digitalis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops digitalis arrhythmia and torsades |  | 
        |  | 
        
        | Term 
 
        | what is the general order for tx htn 12 |  | Definition 
 
        | thiazide diruetic ACE inhibitor / ARB
 CCB
 BB
 other: renin inhibitor, ALD receptor antagonist, a1 adrenergic blocker, a2 agonist, peripherial adrenergic blockers, non-specific adrenergic blockers, vasodilators
 |  | 
        |  | 
        
        | Term 
 
        | what is the general order for tx of CHF 10 |  | Definition 
 
        | ACEI/ARB BB: metaprolol, bisprolol
 Non-specific BB: carvedilol
 amlodipiine
 hydralazine
 inotropic: B agonist, phosphodiesterase inhibitor, nesiritide, digitalis
 |  | 
        |  | 
        
        | Term 
 
        | explain the theatment of eldelry of AA with HTN 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain the TX of HTN post MI 2 |  | Definition 
 
        | 24h: ACEI maintain: ARB, BB
 |  | 
        |  | 
        
        | Term 
 
        | explain the TX of HTN in pt with renal failure 1 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with DM 1 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pregnant pt |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with renal HTN |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is #1 and #2 choice for acute HTN |  | Definition 
 
        | 1. sodium nutroprusside 2. non-specific adrenergic blockers (labelalol, carvedilol)
 |  | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with asthma or peripherial vascular disease |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what HTN drugs can tx diabetic nephropathy 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ther than HTN what can BB treat 4 |  | Definition 
 
        | hyperthyroid migraine prophylaxia
 glaucoma
 cardiomyopathy
 |  | 
        |  | 
        
        | Term 
 
        | other than HTN what can a1 adrenergic blocker tx |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what than HTN what vasodilator has another use, what is it |  | Definition 
 
        | minoxidil: topical male pattern baldness |  | 
        |  | 
        
        | Term 
 
        | what drug do you use in CHF renal failure pt (#1 and #2) |  | Definition 
 
        | DOC: ACEI/ARB 2: hydralazine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chlorthalidone hydrochlorothiazide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 ARN (ANGII receptor blocker) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3 CCB, which can be used for CHF |  | Definition 
 
        | verapamil diatiazem
 amlodipine - CHF and HTN
 |  | 
        |  | 
        
        | Term 
 
        | explain naming of BB, which can be used in CHF |  | Definition 
 
        | A-M B1 selective -olol N-Z B1/2 non-selective -olol
 metapropolol
 bispropolol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 ALD receptor antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | prazosin terazosin
 doxazosin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1 peripherial adrenergic blocker |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 non-specific adrenergic blockers, which is used in CHF |  | Definition 
 
        | labetalol carvedilol - CHF and HTN
 |  | 
        |  | 
        
        | Term 
 
        | 4 vasodilators, which can be used for CHF |  | Definition 
 
        | hydralazine - CHF and HTN minoxidil
 Na nitroprusside
 isorbide dinitrate
 |  | 
        |  | 
        
        | Term 
 
        | 4 categories of inotropic drugs |  | Definition 
 
        | B adrenergic antagonist phosphodiesterase inhibitor
 nesiritide
 digitalis
 |  | 
        |  | 
        
        | Term 
 
        | 1 B adrenergic antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 phosphodiesterase inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is nesiritide made of |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops electrolyte transport causing Na/water excretion 
 decreases BV, CO and BO
 increases urine output
 
 urineoutput, CO, and BV return to normal in days but BP stays fixed due to vascular reactivity to NE and secreased structural resistance
 
 overall: DECREASES PRELOAD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops conversion of ANGI to ANGII and bradyinin to inactive 
 causes vasodilation: inc preload and afterload
 water/NA excretion: dec preload
 prevents ALD cardiac remodel
 
 stops renin feedback and renin builds up
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops ATI receptors so ANGII can't activate ALD or vasoconstrict 
 vasodilation: dec preload and afterload
 water/Na excretion: dec preload
 stops cardiac remodeling
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block L Ca channels in HEART MUSCLE slowing phase 4/0 at AV 
 decreases CO, increases PR, negative inotropic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks L Ca channel in VESSELS AND HEART causing vasodilation and dec CO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block L Ca channels in VESSELS causing vasodilation most likley to cause reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonize B1 on heart dec CO antagonize B1 on JG decreasing renin
 
 vasodilation
 Na/water excretion
 stops cardiac remodeling - some...
 
 improves symptoms, exercise tolerance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | low dose, build over 4-5 wks |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops conversion of angiotensinogen to ANG I 
 vasodilation
 Na/water excretion
 stoms cardiac remodeling - some...
 increased renin due to loss of neg feedback
 |  | 
        |  | 
        
        | Term 
 
        | MOA ALD receptor antagonist |  | Definition 
 
        | K sparing diruetics (not awesome diruetics) block ALD which causes K wasting 
 cause Na/water excretion decreasing preload
 |  | 
        |  | 
        
        | Term 
 
        | MOA a1 adrenergic blockers |  | Definition 
 
        | block a1 on ARTERIOLES AND VEINS causing vasodilation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decrease sympathetic outflow from brainstem vasopressors (main regulator of Na retention) |  | 
        |  | 
        
        | Term 
 
        | MOA peripherial adrenergic blockers |  | Definition 
 
        | blocks reuptake of NE/E causig depletion and decreased SNS 
 vasodilation, dec CO
 |  | 
        |  | 
        
        | Term 
 
        | MOA non-specific adrenergic blockers |  | Definition 
 
        | block A1, B1, B2 decrease TPR without reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NO causes ARTERIOLE dilation (increases flow most) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opens K channels hypopolarizing, dilates ARTERIOLES |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NO dilates VEINS AND ARTERIES |  | 
        |  | 
        
        | Term 
 
        | administration Na nitroprusside |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | VENOdilator, decreases proload |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B adrenergic antagonist: dobutamine, dopanine pisphodiesterase inhibitor: inamirone, milrone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonize B1 and increase CO |  | 
        |  | 
        
        | Term 
 
        | administration dobutamine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | administration of dopamine and effect |  | Definition 
 
        | <2ug/kg: D1 vasodilate renal 2-5ug/kg: V1 inc CO
 5015ug/kg: A1 vasoconstrict, inc TPR
 |  | 
        |  | 
        
        | Term 
 
        | MOA phosphodiesterase inhibitor |  | Definition 
 
        | increase cAMP, phosphorlyates Ca channel increases CO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasodilate veins and arteries |  | 
        |  | 
        
        | Term 
 
        | MOA digtaliz and digitoxin |  | Definition 
 
        | reversibly bind Na/K ATPase chances Ca/Na channel
 Ca comes in
 increases CO
 decreases SNS, TPR
 |  | 
        |  | 
        
        | Term 
 
        | what is the difference between digitalis and digitoxin |  | Definition 
 
        | digitoxin: t1/2: 15d digitalis: t1/2: 48h
 
 toxin is more toxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K depletion (restrict Na intake) increased glucose (don't DC if become diabetic)
 |  | 
        |  | 
        
        | Term 
 
        | interactions thiazide diruetics, why |  | Definition 
 
        | digitallis: messes with Na/K ATPase |  | 
        |  | 
        
        | Term 
 
        | contraindications thiazide diruetics 3, why |  | Definition 
 
        | DM: increases glucose chronic arrhythmia, acute MI: messes with K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | catopril cough: due to brady build up angioedema: face and mouth
 teratogenic
 acute renal failure
 |  | 
        |  | 
        
        | Term 
 
        | why does ACEI cause acute renal failure |  | Definition 
 
        | ANG II constricts efferent arteriole when renal perfusion is low (never use in bilateral renal artery stenosis) |  | 
        |  | 
        
        | Term 
 
        | interactions/contraindications ACEI 2 |  | Definition 
 
        | never use with ARB dont use in renal artery tenosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | teratogenic acute renal failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | constipation dizzy
 naturitic
 |  | 
        |  | 
        
        | Term 
 
        | interactions/contrindications of verpamil 3 |  | Definition 
 
        | no diruetic: its a naturitic no CHF
 no BB
 |  | 
        |  | 
        
        | Term 
 
        | interactions/contrindications of dialtiazem 3 |  | Definition 
 
        | no diruetic: its a naturitic no CHF
 no BB
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | gingival hyperplasia dizzy
 reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 
        | contraindications amlodipine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inc LDL and TG withdrawl: rebount HTN
 hypotension
 bradycardia
 decreased lobido, lethargy
 
 B2: bronchoconstriction, increases glucose
 |  | 
        |  | 
        
        | Term 
 
        | contraindications to BB 2 |  | Definition 
 
        | dont use non-selective in asthmatic or diabetic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | slight cough angioedema
 teratopenic
 |  | 
        |  | 
        
        | Term 
 
        | SE ALD receptor antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | contraindications to ALD receptor antagonist 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how can you prevent hyperkalemia in ALD receptor antagonist |  | Definition 
 
        | use in combo with ACRI/ARB |  | 
        |  | 
        
        | Term 
 
        | SE a1 adrenergic blocker 2 |  | Definition 
 
        | postural HTN on 1st dose dizzy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sedation dry mouth
 withdrawl: rebound HTN
 hemolytic anemia - methyldopa
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sedation bradycardia
 depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bronchoconstriction arrhythmia (C blockade)
 dec lobido
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lupus like in slow acetylators reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 
        | SE Na nitroprusside, why 2 |  | Definition 
 
        | hypotension metabolized to cyanide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anorexia, nausea, vomiting, headache, fatigue, confusion, blurred yellow vision |  | 
        |  | 
        
        | Term 
 
        | digitalis toxicity signs 8, why |  | Definition 
 
        | Ca overload increases automaticity causing DAD leading to ... increased systole
 tachycardia
 PVC
 fibrillation
 complete block
 VTac
 VFib
 |  | 
        |  | 
        
        | Term 
 
        | things that cause predisposition to digitalis toxicity 4 |  | Definition 
 
        | hypoklemia: arrhythmia wuinidine and verapamil: displace it
 diuretics: increase its binding
 |  | 
        |  |